Pharmacokinetic Assessment of Peramivir in Hospitalized Adults Undergoing Continuous Renal Replacement Therapy.

Trial Profile

Pharmacokinetic Assessment of Peramivir in Hospitalized Adults Undergoing Continuous Renal Replacement Therapy.

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 31 Aug 2017

At a glance

  • Drugs Peramivir (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 31 Aug 2017 Last checked against ClinicalTrials.gov record.
    • 25 Feb 2011 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 25 Feb 2011 Planned end date changed from 1 Feb 2012 to 1 Feb 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top